TriSalus Life Sciences (TLSIW) Share-based Compensation (2022 - 2026)

TriSalus Life Sciences (TLSIW) has 5 years of Share-based Compensation data on file, last reported at $2.5 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 52.59% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $10.0 million (up 67.08% YoY), and the FY2025 full-year result was $9.1 million, up 67.82% from the prior year.
• Share-based Compensation for Q1 2026 stood at $2.5 million, up from $2.2 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $3.4 million in Q3 2025 and bottomed at $68000.0 in Q2 2023.
• The 5-year median for Share-based Compensation is $1.3 million (2024), against an average of $1.3 million.
• The widest annual swing landed in 2024, when Share-based Compensation jumped 1775.0%; it then climbed 29.46% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $117000.0 in 2022, then jumped by 754.7% to $1.0 million in 2023, then soared by 69.7% to $1.7 million in 2024, then climbed by 29.46% to $2.2 million in 2025, then climbed by 12.52% to $2.5 million in 2026.
• The last three Share-based Compensation figures came in at $2.5 million (Q1 2026), $2.2 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.

Peer Comparison